Safety of PD-1 Inhibitors in Squamous Non-Small Cell Lung Cancer
2 Visualizações
• 07/14/23
0
0
Embutir
administrator
Assinantes
The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, identify patients with squamous non-small cell lung cancer who may benefit from immune checkpoint inhibitors and the management of any related toxicity.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários